Report: DEA did too little to constrain opioid supply even as crisis escalated
ERIC BARADAT/AFP/GETTY IMAGES
DEA's poor oversight led the agency to increase opioid manufacturing quotas with little regard to misuse, according to a report from a government watchdog.


No hay comentarios:
Publicar un comentario